Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Belgium's Solvay to buy U.S. peer Cytec for $5.5 billion

Published 07/29/2015, 03:39 AM
© Reuters. The statue of Ernest Solvay is seen outside the company's headquarters in Brussels

By Robert-Jan Bartunek

BRUSSELS (Reuters) - Belgian chemical group Solvay (BR:SOLB) has agreed to buy U.S. peer Cytec (N:CYT) for $5.5 billion, giving it a bigger presence in the lightweight materials business where demand from the aerospace industry is booming.

Solvay said in a statement on Wednesday it would pay $75.25 per share for Cytec, which closed at $58.39 on Tuesday.

The Belgian group will finance the transaction with a 1.5 billion euros ($1.66 billion) rights issue, 1.0 billion euros of hybrid debt and a senior debt issue.

Solvay Chief Executive Jean-Pierre Clamadieu said the acquisition was justified by Cytec's growth potential in aerospace markets.

"The composite market in the aerospace sector is growing by about 10 percent per year," he told a conference call. "We are confident Cytec is well positioned to benefit from this growth."

The Belgian company said the enterprise value, which includes debt, was $6.4 billion, representing a 2015 estimated

core profit (EBITDA) multiple of 14.7 times and of 11.7 times when considering potential benefits.

Solvay expects to make annual savings of 100 million euros.

"We consider the acquisition to be a reasonably good fit but consider the price fairly high," KBC Securities wrote in a note.

Solvay shares were 0.9 percent down at 126.85 euros by 0710 GMT, making them among the weaker performers in the FTSEurofirst 300 index (FTEU3) of leading European stocks.

Solvay has previously said it would focus on acquisitions in North America because of lower energy costs. Cytec makes most of its $2 billion in annual sales there.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

It makes composite and adhesive materials for the aerospace and automotive industries and chemicals used in the mining sector for mineral processing and solvent extraction. Solvay already makes chemicals for use in oil and gas extraction.

Clamadieu said he believed the group would secure the necessary regulatory approval on both sides of the Atlantic to close the deal. Solvay expects it will close in the fourth quarter.

The company said that its and Cytec's boards of directors had unanimously recommended the offer and that its largest shareholder, Solvac (BR:SOAC) with a 30 percent stake, was behind the deal.

Solvay also announced its second quarter results on Wednesday. Core profit, adjusted for one-off items rose 8.1 percent in the second quarter to 500 million euros, in line with the 499 million expected in a Reuters poll of seven analysts.

The company said its speciality materials and chemicals businesses gained, but demand declined substantially for chemicals used in the oil and gas sector.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.